Cite
Remodeling Serine Synthesis and Metabolism via Nanoparticles (NPs)‐Mediated CFL1 Silencing to Enhance the Sensitivity of Hepatocellular Carcinoma to Sorafenib.
MLA
Li, Senlin, et al. “Remodeling Serine Synthesis and Metabolism via Nanoparticles (NPs)‐Mediated CFL1 Silencing to Enhance the Sensitivity of Hepatocellular Carcinoma to Sorafenib.” Advanced Science, vol. 10, no. 19, July 2023, pp. 1–15. EBSCOhost, https://doi.org/10.1002/advs.202207118.
APA
Li, S., Xu, L., Wu, G., Huang, Z., Huang, L., Zhang, F., Wei, C., Shen, Q., Li, R., Zhang, L., & Xu, X. (2023). Remodeling Serine Synthesis and Metabolism via Nanoparticles (NPs)‐Mediated CFL1 Silencing to Enhance the Sensitivity of Hepatocellular Carcinoma to Sorafenib. Advanced Science, 10(19), 1–15. https://doi.org/10.1002/advs.202207118
Chicago
Li, Senlin, Lei Xu, Guo Wu, Ziqi Huang, Linzhuo Huang, Fengqian Zhang, Chunfang Wei, et al. 2023. “Remodeling Serine Synthesis and Metabolism via Nanoparticles (NPs)‐Mediated CFL1 Silencing to Enhance the Sensitivity of Hepatocellular Carcinoma to Sorafenib.” Advanced Science 10 (19): 1–15. doi:10.1002/advs.202207118.